BioSpace News Archive

Drug Development

Akebia Therapeutics Announces Full Enrollment of its Global Phase 3 Program of Vadadustat for the Treatment of Anemia Due to Chronic Kidney Disease

INNO2VATE and PRO2TECT now fully enrolled; Company continues to expect to report top-line study results in Q2 of 2020 and mid-2020, respectively, subject to accrual of MACE

September 3, 2019
·
6 min read
BioCapital

Data from Incyte’s Oncology Portfolio to be Featured at the 2019 ESMO Congress

Updated Phase 2 results from the FIGHT-202 study highlight the potential of pemigatinib as a treatment option for patients with previously treated, advanced cholangiocarcinoma

September 3, 2019
·
4 min read
Business

Bayer appoints Marianne De Backer Head of Pharmaceuticals Business Development & Licensing and Member of Executive Committee

Bayer announced Marianne De Backer PhD as the new Head of Business Development & Licensing of its Pharmaceuticals Division.

September 3, 2019
·
3 min read
Business

Alex Crisses Joins Sonendo® Board of Directors

Alex’s area of focus is on investments in General Atlantic’s technology sector, where he leads the thematic sourcing program for General Atlantic and co-heads its Emerging Growth Initiative.

September 3, 2019
·
3 min read
Drug Development

Emmaus Life Sciences Granted European Patent for use of Pharmaceutical-grade L-glutamine in Treating Diverticulosis

Related patents granted in the United States, Japan, Australia, Mexico, China, Indonesia, South Korea and Russia; Patents pending in Brazil and other countries

September 3, 2019
·
3 min read
Biotech Bay

Cesca Therapeutics To Present At The H.C. Wainwright 21st Annual Global Investment Conference

H.C. Wainwright 21st Annual Global Investment Conference on Tuesday, September 10 at 12:30 pm ET. The conference is being held September 8-10 at the Lotte New York Palace Hotel.

September 3, 2019
·
1 min read
Business

Performance Validation is Pleased to Announce that Dalton Pierson and David Tebbe Have Both Successfully Completed the Parenteral Drug Association (PDA) Aseptic Processing Course

We have completed over 33 studies ranging in size from a single hood, to an entire aseptic manufacturing line, we have over 5,500 hours of combined experience in the planning, development and execution/documentation of these studies.

September 3, 2019
·
2 min read
Business

RADiant Treatments Commence at Leading Texas Dermatology Center

RADiant treatment system from Xstrahl, global leader in superficial radiotherapy devices to treat non-melanoma skin cancer and dermatological conditions.

September 3, 2019
·
2 min read
Policy

RMS Medical Products Receives Another Favorable Court Ruling

On November 7, 2017, EMED filed this case in the United States District Court for the Eastern District of Texas claiming patent infringement of the ‘576 Patent by the Company’s needle sets and seeking unspecified monetary damages.

September 3, 2019
·
2 min read
Deals

Avista Capital Partners Acquires GCM, A Leading Outsourced Component Manufacturer For The MedTech Industry

Based in Silicon Valley, GCM is a leading outsourced manufacturer of high-precision components and assemblies, providing an integrated platform of manufacturing solutions primarily for the MedTech industry, as well as select Diversified Industrial end markets

September 3, 2019
·
4 min read